New immunotherapy shows promise for advanced colorectal cancer
Colorectal cancer, also known as bowel cancer, is the third most common cancer worldwide and the second leading cause of cancer deaths. Treatments typically include surgery, radiotherapy, chemotherapy, or immunotherapy, but their efficacy varies depending on the type of bowel cancer. A recent phase 1 trial has found that a combination of two monoclonal antibodies, […]